GI ASCO 2024 Highlights

home / data-dialogue-with-the-oncology-brothers / gi-asco-2024-highlights

Following GI ASCO 2024, Pamela Kunz, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in colorectal cancer, hepatocellular carcinoma, neuroendocrine tumor, and the role of ctDNA.

Rohit Gosain, MD; Rahul Gosain, MD; and Pamela L. Kunz, MD, presenting slides

EP. 1: CheckMate 8HW: Nivolumab Plus Ipilimumab in MSI-High/dMMR Metastatic Colorectal Cancer

Rohit Gosain, MD;Rahul Gosain, MD;Pamela L. Kunz, MD
February 1st 2024

Following ASCO GI 2024, Pamela L. Kunz, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss results from the CheckMate 8HW study investigating nivolumab plus ipilimumab in MSI-high/mismatch repair deficient metastatic colorectal cancer.

Rohit Gosain, MD; Rahul Gosain, MD; and Pamela L. Kunz, MD, presenting slides

EP. 2: EMERALD-1: Durvalumab/Bevacizumab Plus TACE in Unresectable HCC

Rohit Gosain, MD;Rahul Gosain, MD;Pamela L. Kunz, MD
February 1st 2024

Pamela L. Kunz, MD, and the Oncology Brothers provide insights on the EMERALD-1 trial looking at durvalumab and bevacizumab plus TACE in patients with unresectable, embolization-eligible hepatocellular carcinoma.

Rohit Gosain, MD; Rahul Gosain, MD; and Pamela L. Kunz, MD, presenting slides

EP. 3: NETTER-2: Lu-177 Dotatate for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors

Rohit Gosain, MD;Rahul Gosain, MD;Pamela L. Kunz, MD
February 1st 2024

Clinical insights on the recent data from the NETTER-2 trial looking at Lu-177 Dotatate in patients with advanced gastroenteropancreatic neuroendocrine tumors.

Rohit Gosain, MD; Rahul Gosain, MD; and Pamela L. Kunz, MD, presenting slides

EP. 4: The Role of ctDNA in Colorectal Cancer

Rohit Gosain, MD;Rahul Gosain, MD;Pamela L. Kunz, MD
February 1st 2024

Medical oncologists offer comprehensive insights on the role of circulating tumor DNA in the treatment of patients with colorectal cancer.

Rohit Gosain, MD; Rahul Gosain, MD; and Pamela L. Kunz, MD, presenting slides

EP. 5: Key Takeaways from 2024 ASCO GI Cancers Symposium

Rohit Gosain, MD;Rahul Gosain, MD;Pamela L. Kunz, MD
February 1st 2024

Following their review of recent data from the 2024 ASCO GI Cancers Symposium, the Oncology Brothers discuss their key takeaways.